Proliferating Cell Nuclear Antigen as a predictor of therapeutic effect of continuous 5-fluorouracil administration in gastric cancer

International Journal of Oncology

Volumn 14, Issue 5, 1999, Pages 965-970

  Iwatani, Yoshiteru ^a   Kamigaki, Takashi ^a   Suzuki, Satoshi ^a   Ohno, Masakazu ^a   Nakamura, Takeshi ^a   Kuroda, Yoshikazu ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Cell cycle; Gastric cancer; Proliferating cell nuclear antigen

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CYCLINE; DNA; FLUOROURACIL; MESSENGER RNA; RNA; TUMOR MARKER;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; DRUG EFFECT; HUMAN; METABOLISM; NORTHERN BLOTTING; PATHOLOGY; STOMACH TUMOR;

ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, NORTHERN; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; FLUOROURACIL; HUMANS; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033127488     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.5.965     Document Type: Article

References (26)

1. Bravo R, Frank R, Blundell PA and MacDonald BH: Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326: 515-517, 1987.
2. Mathews MB, Bernstein RM, Franza BR Jr and Garrels JI: Identity of the proliferating cell nuclear antigen and cyclin. Nature 309: 374-376, 1984.
3. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH and Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
4. Choi HJ, Jung IK, Kim SS and Hong SH: Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas. Dis Colon Rectum 40: 51-59, 1997.
5. Yonemura Y, Kimura H, Fushida S, Tugawa K, Nakai Y and Kaji M: Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 71: 2448-2453, 1993.
6. Nakamura T, Tabuchi Y, Nakae S, Ohno M and Saitoh Y: Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma: correlation with tumor progression and survival. Cancer 77 (Suppl.): 1741-1746, 1996.
7. Wilke H, Preusser P, Fink U, Achterrath W, Meyer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR and Geerlings H: New developments in the treatment of gastric carcinoma. Semin Oncol 17: 61-70, 1990.
8. Ajani JA, Ota DM, Jessup JM, Ames FC, McBride C, Boddie A, Levine B, Jackson DE, Roh M and Hohn D: Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68: 1501-1506, 1991.
9. Bertino JR, Sawicki WL and Lindquist CA: Schedule-dependent antitumor effect of methotrexate and 5-fluorouracil. Cancer Res 37: 327-328, 1977.
10. Tsujinaka T, Kido Y, Shiozaki H, Iijima S, Homma T, Sakaue M and Takesada M: Schedule-dependent inhibition of thymidylate synthase by 5-fluorouracil in gastric cancer. Cancer 70: 2761-2765, 1992.
11. Leichman L, Silberman H, Leichman CG, Spears CP, Ray M, Muggia FM, Kiyabu M, Radin R, Laine L, Stain S, Fuerst M, Groshen S and Donovan A: Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol 10: 1933-1942, 1992.
12. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L and Danenberg PV: Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 44: 4144-4150, 1984.
13. Pizzorno G, Sun Z and Handschumacher RE: Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil. Biochem Pharmacol 49: 553-557, 1995.
14. Nord LD, Stolfi RL and Martin DS: Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Correlation of antitumor activity with dosage and FUra incorporation into RNA. Biochem Pharmacol 43: 2543-2549, 1992.
15. Sasaki K, Murakami T, Kawasaki M and Takahasi M: The cell cycle associated change of Ki-67 reactive nuclear antigen expression. J Cell Physiol 133: 579-584, 1987.
16. Chang YF, Li LL, Wu CW, Liu TY, Lui WY, P'eng FK and Chi CW: Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77: 14-18, 1996.
17. Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN and Hennessy TP: Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 74: 1693-1698, 1994.
18. Motoyama T, Hojo U and Watanabe H: Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36: 65-83, 1986.
19. Landberg G and Roos G: Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 51: 4570-4574, 1991.
20. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshida K, Iguchi M and Yamate T: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268: 15180-15184, 1993.
21. Miyachi K, Fritzler MJ and Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121: 2228-2234, 1978.
22. Gilbert FM and Michael B: Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856-13864, 1989.
23. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K and Ludwig H: The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor, and mdr gene expression in colorectal cancer. Cancer 71: 2454-2460, 1993.
24. Nakano H, Namatame K, Suzuki T, Takahashi H, Sakai H, Nakamura T and Kumada K: Histopathological response to preoperative chemotherapy including 5-Fluorouracil additionally assessed by immunocytochemical and pharmacologic parameters in patients with advanced gastric cancer. Surg Today 26: 482-488, 1996.
25. Vogt RF, Cross GD, Henderson LO and Phillips DL: Model system evaluating fiuorescein-labeled microbeads as internal standards to calibrate fluorescence intensity of flow cytometers. Cytometry 10: 294-302, 1989.
26. Torres-Ramos CA, Yoder BL, Burgers PMJ, Prakash S and Prakash L: Requirement of proliferating cell nuclear antigen in RAD6-dependent postreplicational DNA repair. Proc Natl Acad Sci USA 93: 9676-9681, 1996.